{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T08:02:28Z","timestamp":1789459348907,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.ahj.2003.07.027","type":"journal-article","created":{"date-parts":[[2004,5,15]],"date-time":"2004-05-15T06:35:24Z","timestamp":1084602924000},"page":"823-827","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Angiotensin-converting enzyme inhibitors as adjunctive therapy in patients with persistent atrial fibrillation"],"prefix":"10.1016","volume":"147","author":[{"given":"Azfar G","family":"Zaman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T","family":"Kearney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clyde","family":"Schecter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen G","family":"Worthley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2003.07.027_BIB1","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1001\/jama.281.19.1830","article-title":"Preventing stroke in patients with atrial fibrillation","volume":"281","author":"Ezekowitz","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2003.07.027_BIB2","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1161\/01.CIR.99.21.2765","article-title":"Double-blind placebo-controlled trial of digoxin in symptomatic paroxysmal atrial fibrillation","volume":"99","author":"Murgatroyd","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2003.07.027_BIB3","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1056\/NEJM199906173402401","article-title":"Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pre-treatment","volume":"340","author":"Oral","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2003.07.027_BIB4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/01.CIR.0000022665.18619.83","article-title":"Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation","volume":"106","author":"Madrid","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2003.07.027_BIB5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/hrt.77.6.527","article-title":"The role of signal averaged P-wave duration and serum magnesium as a combined predictor of atrial fibrillation after elective coronary artery bypass surgery","volume":"77","author":"Zaman","year":"1997","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2003.07.027_BIB6","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/01.CIR.101.12.1403","article-title":"Atrial fibrillation after coronary artery bypass surgery","volume":"101","author":"Zaman","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2003.07.027_BIB7","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/0735-1097(93)90381-A","article-title":"The signal-averaged P-wave duration","volume":"21","author":"Guidera","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2003.07.027_BIB8","doi-asserted-by":"crossref","first-page":"38E","DOI":"10.1016\/0002-9149(87)90200-1","article-title":"Aggravation of arrhythmia by anti-arrhythmic drugs","volume":"59","author":"Podrid","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2003.07.027_BIB9","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/jama.1993.03510130095038","article-title":"Effects of prophylactic anti-arrhythmic drug therapy in acute myocardial infarction","volume":"270","author":"Teo","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2003.07.027_BIB10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1071-9164(05)80004-1","article-title":"Effects of lisinopril in patients with heart failure and chronic atrial fibrillation","volume":"1","author":"Van den Berg","year":"1995","journal-title":"J Card Fail"},{"key":"10.1016\/j.ahj.2003.07.027_BIB11","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1161\/hc4601.099402","article-title":"Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure","volume":"104","author":"Li","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2003.07.027_BIB12","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/01.CIR.100.4.376","article-title":"Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction","volume":"100","author":"Pedersen","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2003.07.027_BIB13","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1161\/01.CIR.88.3.1228","article-title":"Angiotensin I and II exert inotropic effects in atrial but not in ventricular human myocardium","volume":"88","author":"Holubarsch","year":"1993","journal-title":"Circulation"},{"issue":"Suppl D","key":"10.1016\/j.ahj.2003.07.027_BIB14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/eurheartj\/15.suppl_D.88","article-title":"Functional significance of angiotensin receptors in human myocardium","volume":"15","author":"Holubarsch","year":"1994","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2003.07.027_BIB15","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1161\/01.CIR.101.22.2612","article-title":"Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation","volume":"101","author":"Nakashima","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2003.07.027_BIB16","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1161\/01.CIR.101.23.2678","article-title":"Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans","volume":"101","author":"Goette","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2003.07.027_BIB17","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1161\/01.CIR.83.1.162","article-title":"Detection of patients at risk for paroxysmal atrial fibrillation during sinus rhythm by P-wave triggered signal-averaged electrocardiogram","volume":"83","author":"Fukunami","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2003.07.027_BIB18","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1540-8167.1999.tb00244.x","article-title":"Dispersion of filtered P-wave duration by P-wave signal-averaged ECG mapping system","volume":"10","author":"Kubara","year":"1999","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.ahj.2003.07.027_BIB19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0002-9149(96)00720-5","article-title":"Contribution of left atrial pressure and dimension to signal-averaged P-wave duration in patients with chronic congestive heart failure","volume":"79","author":"Faggiano","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2003.07.027_BIB20","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1161\/01.CIR.96.5.1686","article-title":"Effects of atrial dilatation on refractory period of vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart","volume":"96","author":"Ravelli","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2003.07.027_BIB21","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/0002-9149(85)91186-5","article-title":"Effect of enalapril on ventricular arrhythmias in congestive heart failure","volume":"56","author":"Webster","year":"1985","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2003.07.027_BIB22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/01.HYP.28.2.269","article-title":"Advanced hypertensive heart disease in spontaneously hypertensive rats","volume":"28","author":"Brilla","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.ahj.2003.07.027_BIB23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/00004872-199204000-00009","article-title":"Sympathomoderating influence of benazepril in essential hypertension","volume":"10","author":"Giannattasio","year":"1992","journal-title":"J Hypertens"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870303007890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870303007890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:05:52Z","timestamp":1757567152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870303007890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0002870303007890"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2003.07.027","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin-converting enzyme inhibitors as adjunctive therapy in patients with persistent atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2003.07.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}